[
  {
    "ts": null,
    "headline": "Zoetis Inc. (ZTS) Sees Mixed Analyst Sentiment as Targets Are Trimmed",
    "summary": "Zoetis Inc. (NYSE:ZTS) is among the most profitable healthcare stocks to buy. On January 15, Jonathan Block, an analyst at Stifel Nicolaus, reaffirmed a Hold rating and $130 price target on Zoetis Inc. (NYSE:ZTS). As the lowest 1-year price target among Wall Street analysts, the firm’s target translates to an upside potential of 4.91%. Later, […]",
    "url": "https://finnhub.io/api/news?id=db7ff8143993aa73de50976fb5403b747f68bc1eca268f0994b427577a99ad47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769880959,
      "headline": "Zoetis Inc. (ZTS) Sees Mixed Analyst Sentiment as Targets Are Trimmed",
      "id": 138316704,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis Inc. (NYSE:ZTS) is among the most profitable healthcare stocks to buy. On January 15, Jonathan Block, an analyst at Stifel Nicolaus, reaffirmed a Hold rating and $130 price target on Zoetis Inc. (NYSE:ZTS). As the lowest 1-year price target among Wall Street analysts, the firm’s target translates to an upside potential of 4.91%. Later, […]",
      "url": "https://finnhub.io/api/news?id=db7ff8143993aa73de50976fb5403b747f68bc1eca268f0994b427577a99ad47"
    }
  }
]